17 employees
Synthetic Biologics is a biotechnology company developing biologics for the prevention and treatment of serious infectious diseases.
2001
$12M
from 2 investors over 2 rounds
Synthetic Biologics, Inc. raised $12M on September 12, 2017
Investors: BDT & MSD Partners
Synthetic Biologics, Inc. raised $5.6M on September 23, 2013
Investors: EPSRC